Skip to content

Adaptive DBS to Offset STN Dysregulation During Exercise in PD

Implementation of Adaptive DBS to Offset STN Dysregulation During Exercise and Reduce Exertion in Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06296810
Enrollment
10
Registered
2024-03-06
Start date
2024-09-01
Completion date
2025-12-31
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

The investigators conduct a prospective study to evaluate the effects of exercise on Parkinson's Disease brain biomarkers detected with the PerceptTM PC neurostimulator.

Detailed description

The investigators will conduct a prospective study to evaluate the effects of exercise on Local Field Potential biomarkers detected from the subthalmic nuclues in Parkinson's Disease with the PerceptTM PC neurostimulator. Subsequently, adaptive Deep Brain Stimulation applied in response to low beta peak (L-beta; 13-20Hz) will be performed to evaluate feasibility of whether aDBS can offset the effects of exacerbation of parkinsonism during exercise performance and recovery.

Interventions

DEVICEaDBS

adaptive deep brain stimulation

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Persons with PD who have a Medtronic DBS Sensight implant and a Percept IPG. \-

Exclusion criteria

Persons not meeting the above listed implant criteria Persons not meeting the age limit criteria Persons who are not able to complete the study exercise Persons not able to comprehend and consent to study participation.

Design outcomes

Primary

MeasureTime frame
identification of L-beta frequency peak power4 weeks

Countries

United States

Contacts

Primary ContactPamela David Gerecht, PhD
pamela.davidgerecht@cuanschutz.edu303-724-4134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026